Allergies
Arthritis
Arthritis and Acupuncture
Arthritis and Gene Therapy
Therapy and Bone Repair
About Arthritis
Osteoarthritis
Rheumatoid Arthritis
Automimmune diseases
Autoimmune Diseases
About Autoimmune Diseases
Lupus Chinese Medicines
Lupus Treatments
Thrush primary immunodeficiency
Thrush
Bladder problems
Transurethral Resection
About Bladder Problems
Overactive Bladder
Treating Overactive Bladder
Urinary Incontinence Causes
Urinary Incontinence
Urinary Tract Infections and Diet
Urinary Tract Infections
Blood and vascular disorders
Warfarin and Vitamin K
About Blood and Vascular Disorders
Varicose Veins Risks
Varicose Veins
Waldenstroms
Cancer
HRT and Breast Cancer
Research and Breast Cancer
Food Prevention
About Cancer
Kidney Cancer
Kidney Tumors
Leiomyosarcoma
Leukemia Survival
Leukemia
Liver Cancer
Lung Cancer New Treatments
Lung Cancer
Lymphoma Actually Two Forms of Cancer
Lymphoma
Milk Treatment
Mouth Cancer
Oral Cancer Treatment
Ovarian Cancer
Ovarian Cancers Gene Mutations
Pancreatic Cancer Protein Tumor Fighter
Pancreatic Cancer
Prostate Cancer Treatment
Prostate Cancer
Testicular Cancer Transplants
Testicular Cancer
Throat Cancer Your Voice
Throat Cancer
Uterine Cancer Detection
Uterine Cancer
Cholesterol
Diabetes
Diabetes in Children
Diabetes Insipidus
Diabetes Risk
Diabetic Retinopathy
About Diabetes
Peripheral Neuropathy
Type 1 Diabetes
Type 1 Treatment
Type 2 Diabetes
Type 2 Treatment
Erectile dysfunction
Headaches
Heart problems
Heartburn and gerd
Herpes
Hypertension
Causes and Symptoms
Fighting Hypertension
Angiostensin II Blockers
Hypertension Medications
Hypertension-Headaches
About Hypertension
Preventing Hypertension
Intestinal problems
Crohn's Disease
Hormone Therapy
About Intestinal Problems
Irritable Bowel Syndrome
Ulcerative Colitis Self Management
Ulcerative Colitis
Lung diseases
Obesity
Osteoporosis
Pain
About Pain
New Class of Anti-Inflammatory Painkiller
Nervous System
Pain Management Cycles
Pain Management evaluation
Prostate problems
Psychiatric disorders
Alcohol and Dementia
New Molecule to Reduce Amyloid Depostis
Screening Tools for Alzheimers
Blood Flow and Alzheimers
Alzheimer's and Caregivers
Anemia & Dementia
Anxiety and Perception
Child Abuse and Depression
Anxiety and the Adolescent
Coping with Depression
The Elderly
About Psychiatric Disorders
Parkinsons Disease Dopamine
Parkinson's Disease
Teen Health & Depression
Teenage Depression
Salivary glands
Skin disorders
Acne Causes
Laser Treatments for Acne
About Skin Disorders
Psoriasis Treatment
Psoriasis
Rosacea Symptoms
rosacea
Skin Cancer Survival
Skin Cancer
Treatment Options
Sleep
Drugs Sleep Deprivation
About Sleep
Insomnia and Alcohol
Insomnia and Tea
Insomnia
Sleep Disorders Narcolepsy
Sleep Disorders
Students Sleep Deprivation
Turner syndrome
Wellness
Womens health
Reluctance to Seek Help for FSD
About Womens Health
Intranasal Apomorphine HCl
Menopause Symptom Relief
Uterine Fibroids Treatment
Uterine Fibroids
|
New Molecular Marker for Heart Disease FoundMONDAY, February 16, 2004 (HealthDayNews) — Researchers are reporting a new molecular marker that can help doctors assess the risk of heart attack, stroke and other cardiovascular diseases.It is a protein called serum amyloid A (SAA), which is associated with the inflammation that has emerged recently as a leading factor in cardiovascular disease. A new study shows SAA is as useful an indicator of risk as the best-known inflammation marker, C-reactive protein (CRP), says study leader B. Delia Johnson, an epidemiologist and research assistant at the University of Pittsburgh Graduate School of Public Health. "It is better only in the sense that it is actually related to already present coronary artery disease, where CRP isn't," Johnson says. "What still needs to be explored is just how useful it is in respect to CRP. Both are excellent indicators of outcome." That conclusion comes from the Women's Ischemia Syndrome Evaluation study, and the findings appear in the Feb. 17 issue of Circulation. Ischemia is the blockage of arteries that can lead to heart attack, stroke, heart failure and other cardiovascular problems. Johnson and her colleagues looked at the relationship between blood levels of CRP and SAA in 705 women enrolled in the study. All were referred for angiography, a technique that gives images of the arteries in persons suspected to be at risk of cardiovascular problems because they experienced possibly dangerous chest pain. In a three-year follow-up, the risk of a cardiovascular event such as a heart attack, congestive heart failure or stroke increased by 3.2 percent for each increase of 1 milligram per deciliter of SAA. A similar relationship was found for blood levels of CRP. But the SAA levels were more strongly related to the presence of existing artery disease. Many more studies are needed to determine whether and how SAA readings might be used in medical practice, Johnson says. One complication is that SAA is a marker not only of coronary artery disease but also of inflammatory conditions such as rheumatoid arthritis. And it is possible that the results of the study in women might not be directly applicable to men, Johnson adds, because there is a difference in how heart disease affects each of the sexes. "Women who have chest pain and are referred for angiography are less likely to be subject to heart disease than men," she says. "Fewer than 50 percent of them have heart disease, whereas men are much more likely to have heart disease." The study is an important addition to knowledge about SAA because it addresses the different meaning it may have in men and in women, says Dr. Richard C. Becker, a spokesman for the American Heart Association. Becker, a professor of medicine at the Duke University School of Medicine, has an interest in the molecular activity of SAA. It binds to HDL cholesterol, normally the "good" kind that helps keep arteries clear of deposits, and alters it so that it begins to attack artery walls, he explains. "If we can take some of the biology and put it into a working context, for me that opens up a very exciting area," he adds. "At least we can understand such markers better and be able to assess their use in clinical care. Certainly we are getting close to that with CRP." SOURCES: B. Delia Johnson, Ph.D, epidemiologist and research assistant, University of Pittsburgh Graduate School of Public Health, Pittsburgh; Richard C. Becker, professor, medicine, Duke University School of Medicine, Durham, N.C.; Feb. 17, 2004, Circulation; American Heart Association. |
Ads by Yahoo!
Heart Attack Symptoms?
Questions to Ask Your Doctor on a Possible Treatment Option Here. www.PlateletRxInfo.com New Stent after ACS Event Read about a prescription option. www.OralAntiPlateletTherapy.com Heart Disease Manage Your Health - Start Out Your Day w/ Cheerios® Breakfast Cereal www.Cheerios.com |
|
Home
| About Us
| Terms of Use
| Privacy & Security
| Site Map
| © morefocus group, inc. | |
